1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Healthscope's Asian pathology business

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

Singapore

Primary Industry

Healthcare

About

Based in Singapore, Healthscope's Asian pathology business offers pathology services in countries such as Singapore, Malaysia, and Vietnam. In August 2018, the firm was acquired by TPG. Healthscope's Asian pathology business' pathological services include blood tests, urinalysis, stool exams, and other clinical examinations.
Current Investors
TPG

Request a demo to show more

Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only

Deals

Deals Type
Buyout
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Healthscope's Asian pathology business 30 Jul 2018
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.